title: They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.
authors.affiliation: Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI. Schiffer@karmanos.org.
authors.forename: Charles A
authors.initials: CA
authors.lastname: Schiffer
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D007938:Leukemia / Q000628:therapy; D010976:Platelet Count; D017713:Platelet Transfusion / Q000379:methods*; D011322:Primary Prevention / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000628:therapy; D014182:Transplantation, Autologous